welcome
CNBC

CNBC

Health

Health

Moderna stock plunges 18% after company lowers 2025 sales forecast by $1 billion

CNBC
Summary
Nutrition label

84% Informative

Moderna lowered its 2025 sales guidance by roughly $1 billion , as it continues to cut costs.

The biotech company now expects 2025 revenue to come in between $1.5 billion and $2.5 million .

The announcement comes as Moderna charts a path forward after the rapid decline in demand for its Covid vaccine.

VR Score

90

Informative language

91

Neutral language

74

Article tone

informal

Language

English

Language complexity

40

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links